NCT05435599View on ClinicalTrials.gov

Serum Regucalcin Level and Chronic Hepatitis B

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

December 1, 2021

Conditions
Chronic Hepatitis bLiver Fibrosis
Interventions
DIAGNOSTIC_TEST

Serum regucalcin level

During routine outpatient controls, serum regucalcin level will be measured from the rest of the blood taken for examinations.

Trial Locations (1)

42090

Konya Training and Research Hospital, Konya

All Listed Sponsors
lead

Konya Meram State Hospital

OTHER

NCT05435599 - Serum Regucalcin Level and Chronic Hepatitis B | Biotech Hunter | Biotech Hunter